IP Library Granted Patent US 11,666,378
Granted Patent B2
US 11,666,378 · App. 16/701,843 · Granted Jun 6, 2023

Systems and methods for therapeutic nasal neuromodulation

Inventors: David Townley (County Clare, IE); Brian Shields (County Galway, IE)
Assignee: Neurent Medical Limited
A61B18/1485A61B18/14A61B34/10A61B34/20A61N1/0546A61N1/403G06T7/0012A61B18/02A61B18/1206A61B18/20A61B90/92A61B90/94A61B2017/00199A61B2017/00292A61B2017/00424A61B2017/00867A61B2018/0016A61B2018/00166A61B2018/00214A61B2018/00303A61B2018/00327A61B2018/00434A61B2018/00577A61B2018/00654A61B2018/00815A61B2018/00821A61B2018/00875A61B2018/00922A61B2018/00946A61B2018/126A61B2018/1253A61B2018/144A61B2018/1407A61B2018/1467A61B2018/1475A61B2018/1823A61B2034/102A61B2090/376A61B2090/378A61B2090/3735A61B2090/3762A61B2218/007
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,666,378
App. No.
16/701,843
Granted
Jun 6, 2023
Kind
B2
Abstract

The invention generally relates to systems and methods for therapeutically modulating nerves in or associated with a nasal region of a patient for the treatment of a rhinosinusitis condition.

Claims (20)

1. A device for treating a condition within a nasal cavity of a patient, the device comprising:

a shaft;

a multi-segment end effector operably associated with the shaft, the multi-segment end effector comprising a first segment and a separate and distinct second segment spaced apart from the first segment along a longitudinal axis along which a distal-most portion of the shaft lies, wherein each of the first and second segments is transformable between a retracted configuration and an expanded deployed configuration and comprises an associated architecture in the expanded deployed configuration;

wherein the first segment comprises:

a first set of a plurality of flexible support elements that extend in a first outward direction relative to the longitudinal axis and are positioned within a first half of the first segment and cooperatively form an inwardly extending first concave shape when the first segment is in the expanded deployed configuration; and

a second set of a plurality of flexible support elements that extend in a second outward direction relative to the longitudinal axis and substantially opposite the first outward direction and are positioned within a second half of the first segment and cooperatively form an inwardly extending second concave shape opposing the first concave shape when the first segment is in the expanded deployed configuration, the first and second sets of plurality of flexible support elements define the architecture of the first segment when in the expanded deployed configuration; and

a handle operably associated with the shaft, wherein at least the distal-most portion of the shaft comprises one or more markings that provide a user with a spatial orientation of one or more portions of at least the first segment of the multi-segment end effector while the first segment of the multi-segment end effector is in a nasal cavity and in the expanded deployed configuration.

2. The device of claim 1 , wherein a first marking on the distal-most portion of the shaft is associated with one or more flexible support elements of the first set of the plurality of flexible support elements and a second marking on the distal-most portion of the shaft is associated with one or more flexible support elements of the second set of the plurality of flexible support elements.

3. The device of claim 2 , wherein the first marking provides a user with a visual indication of the spatial orientation of the one or more flexible support elements of the first set of the plurality of flexible support elements while the first segment is in a nasal cavity in the expanded deployed configuration.

4. The device of claim 2 , wherein the second marking provides a user with a visual indication of the spatial orientation of the one or more flexible support elements of the second set of the plurality of flexible support elements while the first segment is in a nasal cavity in the expanded deployed configuration.

5. The device of claim 1 , wherein the one or more markings comprise at least one of text, symbols, and color-coding insignia.

6. A method for treating a condition within a nasal cavity of a patient, the method comprising:

providing a treatment device comprising a shaft, a multi-segment end effector operably associated with the shaft, the multi-segment end effector comprising a first segment and a separate and distinct second segment spaced apart from the first segment along a longitudinal axis along which a distal-most portion of the shaft lies, wherein each of the first and second segments is transformable between a retracted configuration and an expanded deployed configuration and comprises an associated architecture in the expanded deployed configuration, wherein the first segment comprises: a first set of a plurality of flexible support elements that extend in a first outward direction relative to the longitudinal axis and are positioned within a first half of the first segment and cooperatively form an inwardly extending first concave shape when the first segment is in the expanded deployed configuration; and a second set of a plurality of flexible support elements that extend in a second outward direction relative to the longitudinal axis and substantially opposite the first outward direction and are positioned within a second half of the first segment and cooperatively form an inwardly extending second concave shape opposing the first concave shape when the first segment is in the expanded deployed configuration, the first and second sets of plurality of flexible support elements define the architecture of the first segment when in the expanded deployed configuration, and a handle operably associated with the shaft wherein at least the distal-most portion of the shaft comprises one or more markings that provide a user with a spatial orientation of one or more portions of at least the first segment of the multi-segment end effector while the first segment of the multi-segment end effector is in a nasal cavity and in the expanded deployed configuration;

advancing the multi-segment end effector to one or more target sites within the nasal cavity of the patient, the multi-segment end effector configured for delivering energy to one or more target sites within the nasal cavity;

positioning at least the first segment of the multi-segment end effector at the one or more target sites based, at least in part, on orientation of the shaft and the one or more markings arranged about the shaft; and

delivering energy from the multi-segment end effector to tissue at the one or more target sites.

7. The method of claim 6 , wherein a first marking on the distal-most portion of the shaft is associated with one or more flexible support elements of the first set of the plurality of flexible support elements and a second marking on the distal-most portion of the shaft is associated with one or more flexible support elements of the second set of the plurality of flexible support elements.

8. The method of claim 7 , wherein the first marking provides a user with a visual indication of the spatial orientation of the one or more flexible support elements of the first set of the plurality of flexible support elements while the first segment is in a nasal cavity in the expanded deployed configuration.

9. The method of claim 7 , wherein the second marking provides a user with a visual indication of the spatial orientation of the one or more flexible support elements of the second set of the plurality of flexible support elements while the first segment is in a nasal cavity in the expanded deployed configuration.

10. The method of claim 6 , wherein the one or more markings comprise at least one of text, symbols, and color-coding insignia.

Assignments (2)
SECURITY INTEREST Recorded Oct 18, 2024
From: NEURENT MEDICAL LIMITED
To: CLARET EUROPEAN SPECIALTY LENDING COMPANY III, S.A R.L.
Reel/Frame 068942/0887 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 21, 2020
From: TOWNLEY, DAVID; SHIELDS, BRIAN
To: NEURENT MEDICAL LIMITED
Reel/Frame 051886/0732 →
Continuity (11)
Provisional Application 62896845 · Sep 6, 2019
Provisional Application 62832927 · Apr 12, 2019
Provisional Application 62832914 · Apr 12, 2019
Provisional Application 62832918 · Apr 12, 2019
Provisional Application 62832923 · Apr 12, 2019
Provisional Application 62832920 · Apr 12, 2019
Provisional Application 62832925 · Apr 12, 2019
Provisional Application 62832928 · Apr 12, 2019
Provisional Application 62832917 · Apr 12, 2019
Provisional Application 62778233 · Dec 11, 2018
Related Publication 20200179681A1 · Jun 11, 2020
Cited By (2)
US 12,484,946 US 12,690,907